Albumin-Bound Paclitaxel /nab-Paclitaxel
Sponsors
National Health Research Institutes, Taiwan, Eye & ENT Hospital of Fudan University, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Shanghai Pulmonary Hospital, Shanghai, China, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Conditions
Biliary CancersExtensive Stage Small Cell Lung Cancer (ES-SCLC)Fallopian Tube CancersGastric Cancer in SituHead & Neck CancerHead and Neck Squamous Cell CarcinomaHead and Neck Squamous Cell Carcinoma (HNSCC)High-grade Serous Ovarian Cancer (HGSOC)
Phase 1
Phase 2
Neoadjuvant Chemotherapy Combined With Finotonlimab in the Treatment of Locally Advanced Hypopharyngeal Carcinoma
RecruitingNCT07248956
Start: 2025-12-22End: 2029-12-30Target: 116Updated: 2025-12-23
Neoadjuvant Aitua (PD-1/CTLA-4 Bispecific) Plus Nab-Paclitaxel and Carboplatin for Advanced High-Grade Serous Ovarian Cancer
Not yet recruitingNCT07432594
Start: 2026-03-01End: 2027-06-30Target: 82Updated: 2026-02-25
Nab-Paclitaxel Combined With Local Therapy in Relapsed SCLC
Not yet recruitingNCT07547332
Start: 2026-04-06End: 2030-12-31Target: 84Updated: 2026-04-23
Nimotuzumab Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma
RecruitingNCT07601737
Start: 2026-04-20End: 2030-04-30Target: 182Updated: 2026-05-22